Latest News

Baron & Budd Moves Forward with False Claims Act Case Against AstraZeneca LP





WASHINGTON–(BUSINESS WIRE)–The nationally recognized attorneys from Baron & Budd are proceeding with a False Claims Act suit against the pharmaceutical company, AstraZeneca LP, after a federal judge denied the company’s request to dismiss the case. U.S. District Judge Maryellen Noreika did, however, agree to dismiss one of the plaintiffs, a former sales specialist for AstraZeneca, from the case. A second plaintiff, represented by the qui tam team at Baron & Budd, remains on the suit.

Source link





Related posts

Worsening air pollution linked to poor mental health

Newsemia

Emerging role of adenosine in brain disorders and amyotrophic lateral sclerosis

Newsemia

Intervention increases healthy behavior among South African adolescents

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy